TrialThe Journal of infectious diseases2022

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.

Susan H Eshleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.